Month: May 2026

BIRMINGHAM, Ala., May 7, 2026 /PRNewswire/ — Books-A-Million is proud to participate in Better Basics Reads, the largest annual volunteer initiative led by education nonprofit Better Basics, bringing the joy of reading to thousands of students across the Birmingham metro area.

On Thursday, May 7, Books-A-Million associates will join hundreds of community volunteers to read in classrooms throughout Birmingham City Schools, helping inspire a love of literacy among young learners. The one-day event is part of a broader, multi-district campaign reaching more than 14,000 students across 42 partner schools.

In support of this effort, Books-A-Million is also making a $30,000 donation to Better Basics to help expand access to books and literacy programming for students across the region.

Formerly known as Birmingham Reads, the Better Basics Reads program mobilizes more than 700 volunteer readers annually, who each spend time reading and engaging in discussion with students in Pre-K through fifth-grade classrooms. The initiative underscores the critical role literacy plays in academic success and lifelong opportunity.

“Research tells us that having books in the home is the single greatest predictor of a child’s academic success,” said Catherine Goudreau, Executive Director of Better Basics. “Putting books into the hands of children is woven into everything we do and Better Basics Reads is the moment we invite the whole community to be part of that effort.”

This year’s program includes participation from Birmingham City Schools, Fairfield City Schools, Bessemer City Schools, i3 Academy, Restoration Academy, and new partner districts Tarrant City Schools and Legacy Prep. Volunteers from across the community—including local organizations, civic leaders, and guest readers—will dedicate time to fostering enthusiasm for reading among students.

For Books-A-Million, headquartered in Birmingham, the initiative reflects a longstanding commitment to literacy, education, and community engagement.

“At Books-A-Million, we believe books have the power to change lives,” said Olivia McDaniel, Vice President of Marketing at Books-A-Million. “Birmingham isn’t just part of our home state—it’s where we’re headquartered, and it’s a community we’re deeply proud to serve. Participating in Better Basics Reads is a meaningful way for us to give back, connect with local students, and help spark a lifelong love of reading.”

In addition to volunteer efforts, Better Basics Reads includes book distributions to ensure students have access to reading materials beyond the classroom—an essential component in building strong literacy skills.

About Books-A-Million

Books-A-Million is the second-largest bookstore retailer in the United States, with more than 220 stores located primarily across the East Coast, South, and Midwest. Founded in 1917 as a small newsstand in Florence, Alabama, the company has grown into a leading bookseller offering a wide range of books, magazines, toys, and gifts. In addition to its brick-and-mortar locations, Books-A-Million operates a robust online storefront and a popular membership-based loyalty program, the Millionaire’s Club, which provides members with exclusive discounts and special offers. Books-A-Million places a strong emphasis on personalized customer service, numerous author events, and a diverse selection of genres and merchandise—catering to a broad spectrum of customers.

Media Contact:
Olivia McDaniel
mcdanielo@booksamillion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/books-a-million-joins-better-basics-reads-donates-30-000-to-support-literacy-for-14-000-birmingham-area-students-302766310.html

SOURCE Books-A-Million, Inc.

Financial results to be released after market close;
Conference call to be conducted at 5:00 p.m. Eastern time

PHOENIX, May 7, 2026 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results.

First Quarter 2026 Conference Call Details

Date and Time: Tuesday, March 12, 2026, at 5:00 p.m. Eastern time

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company’s website at https://app.webinar.net/m976bqQblKE or http://senestech.investorroom.com/.

Replay: A webcast replay will be available in the Investor Relations section of the Company’s website at http://senestech.investorroom.com/ for at least 90 days.

About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable.

For more information, visit https://senestech.com. 

Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases.  You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.  Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations;  and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date.  Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 CONTACT: 

Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026-302766056.html

SOURCE SenesTech, Inc.

Financial results to be released after market close;
Conference call to be conducted at 5:00 p.m. Eastern time

PHOENIX, May 7, 2026 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results.

First Quarter 2026 Conference Call Details

Date and Time: Tuesday, March 12, 2026, at 5:00 p.m. Eastern time

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company’s website at https://app.webinar.net/m976bqQblKE or http://senestech.investorroom.com/.

Replay: A webcast replay will be available in the Investor Relations section of the Company’s website at http://senestech.investorroom.com/ for at least 90 days.

About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable.

For more information, visit https://senestech.com. 

Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases.  You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.  Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations;  and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date.  Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 CONTACT: 

Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026-302766056.html

SOURCE SenesTech, Inc.

Financial results to be released after market close;
Conference call to be conducted at 5:00 p.m. Eastern time

PHOENIX, May 7, 2026 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results.

First Quarter 2026 Conference Call Details

Date and Time: Tuesday, March 12, 2026, at 5:00 p.m. Eastern time

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company’s website at https://app.webinar.net/m976bqQblKE or http://senestech.investorroom.com/.

Replay: A webcast replay will be available in the Investor Relations section of the Company’s website at http://senestech.investorroom.com/ for at least 90 days.

About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable.

For more information, visit https://senestech.com. 

Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases.  You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.  Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations;  and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date.  Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 CONTACT: 

Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026-302766056.html

SOURCE SenesTech, Inc.

Financial results to be released after market close;
Conference call to be conducted at 5:00 p.m. Eastern time

PHOENIX, May 7, 2026 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results.

First Quarter 2026 Conference Call Details

Date and Time: Tuesday, March 12, 2026, at 5:00 p.m. Eastern time

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company’s website at https://app.webinar.net/m976bqQblKE or http://senestech.investorroom.com/.

Replay: A webcast replay will be available in the Investor Relations section of the Company’s website at http://senestech.investorroom.com/ for at least 90 days.

About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable.

For more information, visit https://senestech.com. 

Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases.  You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.  Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations;  and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date.  Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 CONTACT: 

Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026-302766056.html

SOURCE SenesTech, Inc.

LAFAYETTE, Ind., May 7, 2026 /PRNewswire/ — The article outlines mood swings, sleep disturbances, hot flashes, and treatment options including natural bioidentical hormone replacement.

Are mood changes and sleep problems in women in their 40s and 50s signs of hormone imbalance? A HelloNation article provides the answer, featuring insights from Dr. Charles Turner of Innovative Medicine in Lafayette, IN.

The HelloNation article explains that hormone imbalance is common among women in their 40s and 50s as they approach menopause. Fluctuating estrogen and progesterone levels can affect mood, sleep, weight, and overall energy. Recognizing these symptoms early allows for proper evaluation and timely treatment.

Mood swings are often one of the first noticeable changes. Women in their 40s and 50s may experience irritability, anxiety, or sudden emotional shifts without clear external causes. The article notes that hormone imbalance can influence brain chemicals linked to emotional regulation, making mood swings more frequent during menopause.

Sleep disturbances are another common concern. Difficulty falling asleep, waking during the night, or early morning awakenings can become persistent. Hot flashes and night sweats often worsen sleep disturbances, leaving many women in their 40s and 50s feeling fatigued during the day.

Hot flashes and night sweats are hallmark symptoms associated with menopause. These sudden waves of heat and perspiration can interrupt work, social activities, and rest. The article explains that while hot flashes and night sweats are normal during this transition, they may signal underlying hormone imbalance that can be managed effectively.

A thorough medical evaluation is recommended to confirm the cause of symptoms. This process may include reviewing medical history, conducting physical exams, and ordering lab work to assess hormone levels. Identifying hormone imbalance accurately ensures that treatment addresses the true source of discomfort rather than masking symptoms.

Natural bioidentical hormone replacement is presented as a treatment option for many women in their 40s and 50s experiencing menopause related symptoms. This therapy aims to restore hormonal balance in a way that aligns closely with the body’s natural chemistry. When guided by medical supervision, natural bioidentical hormone replacement may help reduce mood swings, hot flashes, and night sweats.

Weight changes and low energy are also discussed. Hormone imbalance can influence metabolism and fat distribution, often leading to increased abdominal weight. Addressing these changes through medical evaluation and natural bioidentical hormone replacement can support improved vitality and overall well being.

Bone and cardiovascular health may also be affected during menopause. Declining estrogen levels contribute to changes in bone density and cholesterol levels. The article notes that early recognition of hormone imbalance provides opportunities for preventive care and long term health planning.

Lifestyle adjustments complement medical treatment. Regular exercise, balanced nutrition, and stress management can help reduce sleep disturbances and support hormonal stability. Combining healthy habits with natural bioidentical hormone replacement often enhances results and improves quality of life.

The HelloNation article concludes that hormone imbalance in women in their 40s and 50s is common but manageable. By recognizing mood swings, sleep disturbances, hot flashes, and night sweats as possible signs of menopause, women can seek timely evaluation and explore natural bioidentical hormone replacement to restore balance and support lasting health.

Signs of Hormone Imbalance in Women in Their 40s & 50s features insights from Dr. Charles Turner, Wellness Expert of Lafayette, IN, in HelloNation.

About HelloNation
HelloNation is a premier media platform that connects readers with trusted professionals and businesses across various industries. Through its innovative “edvertising” approach that blends educational content and storytelling, HelloNation delivers expert-driven articles that inform, inspire, and empower. Covering topics from home improvement and health to business strategy and lifestyle, HelloNation highlights leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-examines-hormone-imbalance-signs-for-women-in-their-40s-and-50s-featuring-wellness-expert-dr-charles-turner-302766209.html

SOURCE HelloNation